Latest Posts

16 Jul 2018

WHY IS STILL TAKING SO LONG TO BUILD A STUDY?

  By Nick O’Brien The Tufts Center for the Study of Drug Development released its 2017 eClinical Landscape Study (outsourcing-pharma.com/Article/2017/10/12/Clinical-trial-database-tribulations-stunt-trial-timelines) late last year, and among the results is a troubling statistic. Companies conducting clinical trials are taking an average of 68 days to build their studies, with 77 percent of survey respondents

0
16 Jul 2018

JEFF SOINSKI INTERVIEW WITH MEDGADGET: AVINGER MAKES P.A.D. TREATMENT SAFER WITH REAL-TIME INTRAVASCULAR IMAGING

  By Michael Batista Peripheral artery disease (P.A.D.), a circulatory condition in which narrowed arteries reduce blood flow to the extremities, is projected to affect more than 21 million patients in the United States by 2020. Common treatments include balloon angioplasty, atherectomy, stenting and bypass, all of which require physicians

0
16 Jul 2018

TOP U.K. SURGEON CALLS FOR NEW PROCEDURES TO UNDERGO CLINICAL TRIALS IN ENGLAND

  Prof Derek Alderson, MD and the president of the Royal College of Surgeons, said the benefits of surgical innovations in the United Kingdom must “absolutely, unequivocally” be backed by evidence, either through randomised controlled trials or official registries designed to track patient outcomes. The move would bring surgical innovation

0
16 Jul 2018

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.). Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D. The Company intends to launch two versions

0
16 Jul 2018

MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS

Med-Aesthetic Solutions Inc., the developer and manufacturer of the proprietary SaltFacial skin renewal system, has formed a partnership with Aesthetic Management Partners to represent its product line exclusively, in select markets worldwide. The partnership commenced with a strong presence at The Aesthetic Show in Las Vegas in July. Aesthetic Management

0
SHARE

Home